“TREATMENT OF TYPE 2 DIABETES MELLITUS WITH GLP-1 RECEPTOR AGONISTS, CHRONIC KIDNEY DISEASE AND INFLUENCE ON CARDIOVASCULAR RISK”, TJS, vol. 23, no. Supplement 1, p. 6, Oct. 2025, doi: 10.15547/tjs.2025.s.01.004.